Voxel-Based Morphometry Analysis of Structural MRI for Differentiation Between Dementia with Lewy Bodies and Alzheimer’s Disease [Letter]

Código QR

Voxel-Based Morphometry Analysis of Structural MRI for Differentiation Between Dementia with Lewy Bodies and Alzheimer’s Disease [Letter]

Shohei Inui, 1, 2 Keita Sakurai, 1 Yoshio Hashizume 3 1Department of Radiology, Teikyo University School of Medicine, Tokyo, Japan; 2Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 3Choju Medical Institute, Fukushimura Hospital, Aichi, JapanCorresponde...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Inui S, Sakurai K, Hashizume Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/24cea76570a049faa1a2b9d579792090
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Differentiation Between Dementia With Lewy Bodies And Alzheimer’s Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study
por: Matsuda H, et al.
Publicado: (2019)

Advances in dementia with Lewy bodies
por: Melissa J. Armstrong
Publicado: (2021)

Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer&rsquo;s disease: a voxel-based morphometry study
por: Nakaaki S, et al.
Publicado: (2012)

Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer’s disease with dementia Lewy bodies
por: Onofri E, et al.
Publicado: (2015)

Effects of carbonated liquid on swallowing dysfunction in dementia with Lewy bodies and Parkinson’s disease dementia
por: Larsson V, et al.
Publicado: (2017)

Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment
por: Ozkan S, et al.
Publicado: (2013)

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
por: Fereshtehnejad SM, et al.
Publicado: (2013)

Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case series
por: Sugawara Kikuchi Y, et al.
Publicado: (2019)

Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry
por: Hashimoto N, et al.
Publicado: (2014)

Could lysine supplementation prevent Alzheimer&rsquo;s dementia? A novel hypothesis
por: Robert N Rubey
Publicado: (2010)

The Feasibility of Differentiating Lewy Body Dementia and Alzheimer’s Disease by Deep Learning Using ECD SPECT Images
por: Yu-Ching Ni, et al.
Publicado: (2021)

Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
por: Samtani MN, et al.
Publicado: (2014)

Association of EEG, MRI, and regional blood flow biomarkers is predictive of prodromal Alzheimer’s disease
por: Moretti DV
Publicado: (2015)

Global and regional brain volumes normalization in weight-recovered adolescents with anorexia nervosa: preliminary findings of a longitudinal voxel-based morphometry study
por: Bomba M, et al.
Publicado: (2015)

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
por: Montgomery W, et al.
Publicado: (2018)

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.
por: Elisabeth Kapaki, et al.
Publicado: (2013)

Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.
por: Niklas K U Koehler, et al.
Publicado: (2013)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography
por: Ortner M, et al.
Publicado: (2019)

Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
por: Nicholas P. Marotta, et al.
Publicado: (2021)

Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2
por: Kazunori Sano, et al.
Publicado: (2021)

Magnetic resonance spectroscopy in Alzheimer’s disease
por: Graff-Radford J, et al.
Publicado: (2013)

Focal retrograde amnesia: voxel-based morphometry findings in a case without MRI lesions.
por: Bernhard Sehm, et al.
Publicado: (2011)

Update on the use of memantine in Alzheimer&rsquo;s disease
por: Robert J van Marum
Publicado: (2009)

Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies
por: Sung Woo Kang, et al.
Publicado: (2021)

Identification of a Qualitative Signature for the Diagnosis of Dementia With Lewy Bodies
por: Shu Zhou, et al.
Publicado: (2021)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

Nutrition Challenges of Patients with Alzheimer’s Disease and Related Dementias: A Qualitative Study from the Perspective of Caretakers in a Mental National Referral Hospital
por: Kigozi E, et al.
Publicado: (2021)

Activation of mTOR: a culprit of Alzheimer’s disease?
por: Cai Z, et al.
Publicado: (2015)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)

Role of berberine in Alzheimer’s disease
por: Cai Z, et al.
Publicado: (2016)

Neuroanatomical correlates of the perception of body axis orientation during body tilt: a voxel-based morphometry study
por: Keisuke Tani, et al.
Publicado: (2021)

It Is Time to Study Overlapping Molecular and Circuit Pathophysiologies in Alzheimer’s and Lewy Body Disease Spectra
por: Noritaka Wakasugi, et al.
Publicado: (2021)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
por: Fowler NR, et al.
Publicado: (2018)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
por: J&uuml;rgen G&ouml;tz, et al.
Publicado: (2008)

Intrathecal corticosteroids might slow Alzheimer&rsquo;s disease progression
por: Joseph Martin Alisky
Publicado: (2008)

Caregiver burden and coping strategies in caregivers of patients with Alzheimer’s disease
por: Iavarone A, et al.
Publicado: (2014)

Present and prospective clinical therapeutic regimens for Alzheimer&rsquo;s disease
por: Mustafa M Husain, et al.
Publicado: (2008)